Kamiya Mehla to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Kamiya Mehla has written about Antimetabolites, Antineoplastic.
Connection Strength
0.187
-
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar; 67(3):445-457.
Score: 0.147
-
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. J Pharmacol Exp Ther. 2019 09; 370(3):894-901.
Score: 0.040